Bill Oxford/iStock via Getty Images
Shares of CRISPR Therapeutics (NASDAQ:CRSP) were on track to snap six straight days of gains, as the stock fell more than 4% to $50.80 in Thursday afternoon trade.
The Switzerland-based biotech company gained more than 33% in the last six trading
